India · Delayed Price · Currency is INR Novelix Pharmaceuticals Statistics
Total Valuation
BOM:536565 has a market cap or net worth of INR 1.71 billion. The enterprise value is 1.72 billion.
| Market Cap | 1.71B |
| Enterprise Value | 1.72B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:536565 has 28.47 million shares outstanding. The number of shares has increased by 122.66% in one year.
| Current Share Class | 28.47M |
| Shares Outstanding | 28.47M |
| Shares Change (YoY) | +122.66% |
| Shares Change (QoQ) | -15.57% |
| Owned by Insiders (%) | 34.84% |
| Owned by Institutions (%) | 0.88% |
| Float | 7.78M |
Valuation Ratios
The trailing PE ratio is 39.99.
| PE Ratio | 39.99 |
| Forward PE | n/a |
| PS Ratio | 1.16 |
| PB Ratio | 3.68 |
| P/TBV Ratio | 3.83 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 47.48 |
| EV / Sales | 1.17 |
| EV / EBITDA | 37.59 |
| EV / EBIT | 38.58 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.94, with a Debt / Equity ratio of 0.09.
| Current Ratio | 1.94 |
| Quick Ratio | 1.40 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.94 |
| Debt / FCF | n/a |
| Interest Coverage | 38.70 |
Financial Efficiency
Return on equity (ROE) is 7.99% and return on invested capital (ROIC) is 8.15%.
| Return on Equity (ROE) | 7.99% |
| Return on Assets (ROA) | 3.58% |
| Return on Invested Capital (ROIC) | 8.15% |
| Return on Capital Employed (ROCE) | 7.38% |
| Weighted Average Cost of Capital (WACC) | 5.57% |
| Revenue Per Employee | 45.91M |
| Profits Per Employee | 1.13M |
| Employee Count | 32 |
| Asset Turnover | 2.21 |
| Inventory Turnover | 16.61 |
Taxes
In the past 12 months, BOM:536565 has paid 7.22 million in taxes.
| Income Tax | 7.22M |
| Effective Tax Rate | 16.59% |
Stock Price Statistics
The stock price has increased by +24.76% in the last 52 weeks. The beta is 0.25, so BOM:536565's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | +24.76% |
| 50-Day Moving Average | 72.68 |
| 200-Day Moving Average | 64.83 |
| Relative Strength Index (RSI) | 30.07 |
| Average Volume (20 Days) | 3,647 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:536565 had revenue of INR 1.47 billion and earned 36.29 million in profits. Earnings per share was 1.50.
| Revenue | 1.47B |
| Gross Profit | 71.03M |
| Operating Income | 44.66M |
| Pretax Income | 43.50M |
| Net Income | 36.29M |
| EBITDA | 45.82M |
| EBIT | 44.66M |
| Earnings Per Share (EPS) | 1.50 |
Balance Sheet
The company has 29.59 million in cash and 43.22 million in debt, with a net cash position of -13.63 million or -0.48 per share.
| Cash & Cash Equivalents | 29.59M |
| Total Debt | 43.22M |
| Net Cash | -13.63M |
| Net Cash Per Share | -0.48 |
| Equity (Book Value) | 464.88M |
| Book Value Per Share | 22.05 |
| Working Capital | 429.76M |
Cash Flow
In the last 12 months, operating cash flow was -223.89 million and capital expenditures -32.56 million, giving a free cash flow of -256.45 million.
| Operating Cash Flow | -223.89M |
| Capital Expenditures | -32.56M |
| Depreciation & Amortization | 1.17M |
| Net Borrowing | n/a |
| Free Cash Flow | -256.45M |
| FCF Per Share | -9.01 |
Margins
Gross margin is 4.84%, with operating and profit margins of 3.04% and 2.47%.
| Gross Margin | 4.84% |
| Operating Margin | 3.04% |
| Pretax Margin | 2.96% |
| Profit Margin | 2.47% |
| EBITDA Margin | 3.12% |
| EBIT Margin | 3.04% |
| FCF Margin | n/a |
Dividends & Yields
BOM:536565 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -122.66% |
| Shareholder Yield | -122.66% |
| Earnings Yield | 2.50% |
| FCF Yield | -15.01% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 4, 2010. It was a reverse split with a ratio of 0.1.
| Last Split Date | Oct 4, 2010 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |